-
Recent Posts
- Overexpression of protrudin in primary cortical neurons enhances regeneration after laser axotomy through multiple mechanisms
- Lin28 protein regulates CNS axon regeneration in adult mammalians
- Case Western Reserve Researchers Restore Breathing and Partial Forelimb Function in Rats with Chronic Spinal Cord Injuries
- Elevated phosphoinositide 3-kinase activity promotes axon regeneration of central nervous system neurons
- Identifying the most effective types of integration-free human iPS cell-derived neural stem/progenitor cells in the treatment of spinal cord injury
- Alterations in spinal cord injury-induced plasticity of spinal rhythm generating interneurons following treadmill training with epidural stimulation in mouse
- École Polytechnique Fédérale de Lausanne (EPFL) has implanted SCI trial patient walking 1/2 mile.
- Nerve-on-a-Chip to Improve Functionality of Neuroprosthetic Devices
- Perspectives on “the biology of spinal cord regeneration success and failure”
- Neuroplasticity after Spinal Cord Injury
- SCI Research and Rehabilitation: Mayo Clinic Radio
- Therapeutic Stimulation for Restoration of Function After Spinal Cord Injury
- Louis and Harold Price Foundation boosts SCI work at the Dr. Daniel Lu Laboratory with $3M gift
- BioAxone receives fast track grant for Rho Kinase 2 inhibitor to improve outcomes in chronic SCI
- SCI Trial Report Standing and Walking with Electrical Stimulation at Mayo
A Journey into SCI Research and Science Begins
Chris Powell and son Brandon SCI Survivor (2005)
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Lisa McKerracher
BioAxone receives fast track grant for Rho Kinase 2 inhibitor to improve outcomes in chronic SCI
CAMBRIDGE, Mass.–(BUSINESS WIRE)–BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant (R44 NS110290-01) from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, as part of the agency’s Small Business Innovation … Continue reading
Posted in Chronic Spinal Cord Injury Research, Spinal Research
Tagged BioAxone BioSciences, Lisa McKerracher
UC Davis surgeons enroll the first patient in an acute spinal cord injury study
This compound was previously known as Cethrin. Dr Lisa McKerracher is Founder of BioAxone and inventor of Cethrin. It is being developed by Vertex Pharmaceuticals. UC Davis Health System – Sacramento, California – Neurosurgeons at UC Davis Health System have … Continue reading
Posted in Spinal Research
Tagged Cethrin, Lisa McKerracher, Vertex Pharmaceuticals, VX-210
2 Comments
